Trial outcomes
Trial outcomes were assessed at a follow-up visit 21 days after albendazole treatment. The co-primary outcomes were two commonly-used representative indicators to determine anthelminthic drug efficacy: cure rate (CR) and egg reduction rate (ERR) [